We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.2B
AUM Growth
-$360M
(-0.85%)
Cap. Flow
-$2.32B
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
7.6%
Holding
2,945
New
147
Increased
1,226
Reduced
1,320
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$859M |
| 2 |
Apple
AAPL
|
+$61.2M |
| 3 |
Norwegian Cruise Line
NCLH
|
+$56M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.7M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$106M |
| 2 |
ULQ
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
|
+$84.5M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$53.6M |
| 4 |
Applied Materials
AMAT
|
+$37.5M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.48% |
| 2 | Financials | 12.95% |
| 3 | Healthcare | 12.03% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Verastem
VSTM
$500M
| $34K | ﹤0.01% |
933
-116
| -11% | -$5.24K |
|
|
ALSK
2652
DELISTED
Alaska Communications Systems
ALSK
| $33K | ﹤0.01% |
12,333
-1,540
| -11% | -$3.61K |
|
|
CVRS
2653
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $33K | ﹤0.01% |
32,490
-3,987
| -11% | -$4.51K |
|
2654
Genasys
GNSS
$78.3M
| $32K | ﹤0.01% |
12,781
-1,596
| -11% | -$3.42K |
|
|
CTIC
2655
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $32K | ﹤0.01% |
11,850
-1,480
| -11% | -$4.34K |
|
|
TURN
2656
DELISTED
180 Degree Capital
TURN
| $30K | ﹤0.01% |
5,154
-643
| -11% | -$3.82K |
|
|
UQM
2657
DELISTED
UQM Technologies, Inc.
UQM
| $29K | ﹤0.01% |
20,646
-2,578
| -11% | -$3.29K |
|
|
LUNA
2658
DELISTED
Luna Innovations Incorporated
LUNA
| $29K | ﹤0.01% |
12,021
-1,501
| -11% | -$2.94K |
|
2659
Protalix BioTherapeutics
PLX
$187M
| $27K | ﹤0.01% |
4,014
-501
| -11% | -$3.38K |
|
|
RGLS
2660
DELISTED
Regulus Therapeutics
RGLS
| $27K | ﹤0.01% |
216
-26
| -11% | -$3.29K |
|
|
INFI
2661
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $27K | ﹤0.01% |
13,406
-1,674
| -11% | -$3.47K |
|
|
LITS
2662
Lite Strategy Inc
LITS
$33.4M
| $26K | ﹤0.01% |
608
-76
| -11% | -$3.57K |
|
2663
WidePoint Corp
WYY
$103M
| $26K | ﹤0.01% |
4,067
-507
| -11% | -$3.11K |
|
|
ROYT
2664
DELISTED
PACIFIC COAST OIL TRUST
ROYT
| $26K | ﹤0.01% |
13,231
-1,652
| -11% | -$2.7K |
|
|
RLOG
2665
DELISTED
Rand Logistics, Inc.
RLOG
| $24K | ﹤0.01% |
154,628
| – | – |
|
2666
Matinas BioPharma
MTNB
$1.93M
| $23K | ﹤0.01% |
+415
| New | +$26.7K |
|
2667
Talphera
TLPH
$69M
| $22K | ﹤0.01% |
533
-67
| -11% | -$3.27K |
|
|
ALIM
2668
DELISTED
Alimera Sciences
ALIM
| $22K | ﹤0.01% |
1,126
-140
| -11% | -$2.73K |
|
|
TRVN
2669
DELISTED
Trevena, Inc.
TRVN
| $22K | ﹤0.01% |
21
-3
| -13% | -$3.26K |
|
|
SNMX
2670
DELISTED
Senomyx, Inc.
SNMX
| $22K | ﹤0.01% |
17,005
-2,124
| -11% | -$2.4K |
|
|
ALR
2671
DELISTED
AlerisLife Inc
ALR
| $21K | ﹤0.01% |
1,410
-176
| -11% | -$2.73K |
|
2672
Globalstar
GSAT
$10.8B
| $20K | ﹤0.01% |
997
+58
| +6% | +$1.32K |
|
2673
Vivani Medical
VANI
$115M
| $20K | ﹤0.01% |
430
-54
| -11% | -$1.79K |
|
|
TST
2674
DELISTED
TheStreet, Inc.
TST
| $20K | ﹤0.01% |
1,361
-170
| -11% | -$2.08K |
|
|
VRML
2675
DELISTED
Vermillion, Inc.
VRML
| $20K | ﹤0.01% |
10,523
-1,314
| -11% | -$2.21K |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
NMIFOAC
WANY
ACA
Guggenheim Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Guggenheim Capital held 2,945 positions worth $42.2B, down 0.85% from $42.6B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Guggenheim Capital withdrew a net $2.32B in Q4 2017, closing 236 positions and reducing 1,320 holdings. Its most notable exit was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF, an estimated $84.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Guggenheim Capital opened a new position in iShares China Large-Cap ETF worth $18M.
- Guggenheim Capital's largest Q4 2017 buy was iShares China Large-Cap ETF: 389,755 shares worth $18M.
- Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $859M increase.
- Guggenheim Capital's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $106M.
- Guggenheim Capital fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q4 2017, selling an estimated $84.5M.
- Guggenheim Capital's ten largest holdings make up 7.6% of its $42.2B portfolio in Q4 2017.
- Guggenheim Capital opened 147 new positions and closed 236 in Q4 2017.
- Guggenheim Capital's portfolio value fell 0.85% quarter-over-quarter to $42.2B.
Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.